Insider Purchases: Inside the Buy
Tag: Contrarian Investment
Fox Factory: Left for Roadkill or Setting Up a Suspension Rebound?
Fox Factory (FOXF) went from high-flyer to face-plant, trading over 90% below its peak — yet the CEO and big institutions keep buying. Is this a stealth value opportunity or a suspension story that never quite rebounds? Let’s dig in, with jokes and numbers.
Dexcom’s COO Just Bought ~$1M of Stock — Sweet Signal or Just a Sugar Rush?
Dexcom’s insider buy just spiked the glucose of Wall Street chat rooms. The COO is buying big, AI features are rolling, and institutions own almost everything. Is DXCM a sweet buy or a sugar rush in disguise? 🍬📈
Insiders Had Bought Shares of Elanco Animal Health (ELAN); Turns Out They Were Right — And It May Only Be the Beginning!
Insiders bought millions of Elanco shares under $15 — and they were right. Now, with JP Morgan’s upgrade and revenues rising, this stock might be a hidden gem in the animal health world. 🐾
Tilray of Sunshine: CEO Bought Shares Weeks Ago — and Now Earnings Are Finally Rolling In
Tilray finally posted profits and a healthy cash flow — and insiders bought in early. Could this be the long-awaited turnaround, or just another puff of smoke?
CarMax (KMX): Where Insiders Keep Buying — And Cars Keep Driving Off (Mostly the Lot)
Insiders and institutions are revving up for CarMax’s comeback — even as used car sales slow and margins tighten. With shares 70% below their peak and a major digital overhaul underway, this could be the turnaround ride of the year. 🚘📉 Or just another trip to the mechanic.